0001666071-24-000057.txt : 20240402 0001666071-24-000057.hdr.sgml : 20240402 20240402202242 ACCESSION NUMBER: 0001666071-24-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Temsamani Karim Saad CENTRAL INDEX KEY: 0001944491 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 24816530 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] ORGANIZATION NAME: 06 Technology IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 4100 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 4100 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wk-form4_1712103752.xml FORM 4 X0508 4 2024-04-01 0 0001666071 Cardlytics, Inc. CDLX 0001944491 Temsamani Karim Saad 675 PONCE DE LEON AVE. NE SUITE 4100 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-04-01 4 M 0 50000 A 377298 D Common Stock 2024-04-02 4 S 0 32564 13.69 D 344734 D Common Stock 2024-04-01 4 S 0 154 14.41 D 344580 D Restricted Stock Unit 2024-04-01 4 M 0 50000 0 D Common Stock 50000 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Shares were sold solely to satisfy withholding tax obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2024. The Reporting Person did not sell shares for any other purpose. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.40 to $14.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) and (4). The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.41, inclusive. This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024 and April 1, 2024. /s/ Nick Lynton, Attorney-in-Fact 2024-04-02